Patents by Inventor Man Chen

Man Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230074613
    Abstract: Disclosed are an antibody combination for one-step screening and/or diagnosis of clonal diseases and application thereof. The antibody combination includes eight groups of antibodies, and is a set of flow cytometry detection panels for one-step screening and/or diagnosis of clonal diseases, and 5-tube parallel is used for one sample, the first group of antibodies and the second group of antibodies are used for samples in different flow cytometry tubes, the third group of antibodies and the sixth group of antibodies are used for samples in the same flow cytometry tube, the fourth group of antibodies and the seventh group of antibodies are used for samples in the same flow cytometry tube, and the fifth group of antibodies and the eighth group of antibodies are used for samples in the same flow cytometry tube.
    Type: Application
    Filed: August 3, 2022
    Publication date: March 9, 2023
    Applicants: SYNARC RESEARCH LABORATORY (BEIJING) LTD., HEBEI YANDA LU DAOPEI HOSPITAL
    Inventors: Hui WANG, Man CHEN, Aixian WANG, Meiwei GONG, Xueying WU, Junyi ZHEN, Qing DU, Ya GUO
  • Publication number: 20230074660
    Abstract: The present invention provides a detection reagent and therapeutic target for B cell tumor after targeted therapy and related applications. The reagent composition comprises 3 groups of antibodies, with the first group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD24 an antibody, an anti-CD20 antibody, an anti-CD81 antibody, an anti-CD45 antibody; the second group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD20 antibody, an anti-CD72 antibody, an anti-CD45 antibody; and the third group of antibodies including an anti-cytoplasmic CD79a antibody. The reagent composition of the present invention can be applied for the detection of B-lymphocyte tumors after targeted therapy by flow cytometry.
    Type: Application
    Filed: May 25, 2022
    Publication date: March 9, 2023
    Applicants: Synarc Research Laboratory (Beijing) Ltd., HEBEI YANDA LUDAOPEI HOSPITAL
    Inventors: Hui WANG, Man CHEN, Aixian WANG, Meiwei GONG, Xueying WU, Junyi ZHEN, Qing DU, Ya GUO
  • Publication number: 20230014368
    Abstract: A disassembling device for removing fastening components embedded in a workpiece includes a supporting base, a clamping assembly, and a pushing assembly. The pushing assembly includes a sliding assembly, an adjusting rod, and an ejecting pin. The workpiece defines a first through hole which communicates with a positioning hole. The workpiece is clamped by the clamping assembly, the sliding assembly is connected to the supporting base and can slide along a first direction and a second direction perpendicular to the first direction. The adjusting rod passes through the sliding assembly to connect with the ejecting pin, the ejecting pin is driven to extend into the first through hole and to move in a direction perpendicular to the first and second directions, so as to push the fastening component out of the positioning hole.
    Type: Application
    Filed: April 22, 2022
    Publication date: January 19, 2023
    Inventor: YONG-MAN CHEN
  • Publication number: 20220350476
    Abstract: An electronic device, a method, and a computer-readable recording medium are provided for deactivating a chat room of a messenger application. The electronic device is configured for: receiving a deactivation request for one or more chat rooms, in which the deactivation request is associated with a chat room configuration, and the chat room configuration includes a deactivation condition for the one or more chat rooms; storing the chat room configuration including the deactivation condition for the one or more chat rooms based on the deactivation request; and deactivating the one or more chat rooms based on determining whether or not the deactivation condition for the one or more chat rooms is satisfied.
    Type: Application
    Filed: July 13, 2022
    Publication date: November 3, 2022
    Applicants: LINE CORPORATION, LINE Plus Corporation
    Inventors: Ching-hsiang TSAI, Chien-ju LIN, Man-chen WU, Kuan-wei LIN
  • Publication number: 20220326122
    Abstract: The present disclosure provides a self-adaption faster-than-real-time method for estimating a working condition start-up state of a unit. Firstly, an event recording sequence, an analog measurement point ID, an analog measurement point first-level alarm value and a history scatter point distribution record are read from a time sequence event record table, an analog measurement point table, an alarm threshold table and a historical scatter record table. A measured value slope of the analog measurement point is calculated according to an event recording relative time. Then, an abnormal state estimated value is calculated based on the history scatter point distribution record, the analog measurement point first-level alarm value and the measured value slope of the analog measurement point. Finally, a pre-warning is sent to remind a watchman to perform a preventive operation when the abnormal state estimated value is above the threshold.
    Type: Application
    Filed: September 30, 2020
    Publication date: October 13, 2022
    Applicant: CSG POWER GENERATION CO., LTD.
    Inventors: Hao ZHANG, Man CHEN, Yu GONG, Yumin PENG, Xiong DAI, Mingxuan YANG, Xiaobo QIU, Mingliang YAO, Yaxiong YU, Jun SHE, Rufei HE, Yanming GAO, Dehua LI, Xianbin GUO, Xiaoyi WANG
  • Publication number: 20220317646
    Abstract: The present disclosure provides a self-adaptive test method for an intelligent prediction algorithm of analog measured values. Firstly, an event recording sequence, an analog measurement point ID and an analog measurement point alarm value are read from a time sequence event record table, an analog measurement point table and an alarm threshold table. Next, operation records of a normal operation state of a unit within a statistical cycle are acquired to form historical statistics of measured values of the analog measurement point based on switching value signals. Then, simulated measured values of the analog measurement point with time scales are calculated based on the historical statistics, the analog measurement point alarm value and an analog measurement point current measured value. Finally, sensitivity is calculated; and an alarm is sent to remind a technician to adjust the algorithm when the sensitivity is greater than a threshold.
    Type: Application
    Filed: September 30, 2020
    Publication date: October 6, 2022
    Applicant: CSG POWER GENERATION CO., LTD.
    Inventors: Hao ZHANG, Man CHEN, Yu GONG, Yumin PENG, Xiong DAI, Mingxuan YANG, Xiaobo QIU, Mingliang YAO, Yaxiong YU, Jun SHE, Rufei HE, Yanming GAO, Zhenglin XIANG, Jianqiu LI, Dehua LI, Xianbin GUO, Xiaoyi WANG
  • Publication number: 20220064222
    Abstract: Embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the RSV F ectodomain trimer and methods of producing the RSV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer to the subject.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Peter Kwong, Barney Graham, John Mascola, Li Ou, Aliaksandr Druz, Man Chen, Wing-Pui Kong, Ivelin Stefanov Georgiev, Emily Rundlet, Michael Gordon Joyce, Yaroslav Tsybovsky, Paul Thomas, Marie Pancera, Mallika Sastry, Cinque Soto, Joseph Van Galen, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Ulrich Baxa
  • Publication number: 20220002351
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Application
    Filed: September 17, 2021
    Publication date: January 6, 2022
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Servic
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou
  • Patent number: 11174292
    Abstract: Embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the RSV F ectodomain trimer and methods of producing the RSV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer to the subject.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: November 16, 2021
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter Kwong, Barney Graham, John Mascola, Li Ou, Aliaksandr Druz, Man Chen, Wing-Pui Kong, Ivelin Stefanov Georgiev, Emily Rundlet, Michael Gordon Joyce, Yaroslav Tsybovsky, Paul Thomas, Marie Pancera, Mallika Sastry, Cinque Soto, Joseph Van Galen, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Ulrich Baxa
  • Publication number: 20210340436
    Abstract: Disclosed is a polymer dispersion prepared by controlled radical polymerization and a use of the polymer dispersion as a friction reducer in oil field processes.
    Type: Application
    Filed: October 11, 2018
    Publication date: November 4, 2021
    Applicant: RHODIA OPERATIONS
    Inventors: Zhenxing Cheng, Zhihua Zhang, Man Chen, Chee Fei Chin, David James Wilson
  • Patent number: 11130785
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: September 28, 2021
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou
  • Patent number: 10858400
    Abstract: Disclosed are immunogens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the immunogens and methods of producing the immunogens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the immunogen to the subject.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: December 8, 2020
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter Kwong, Barney Graham, Jason McLellan, Man Chen, Baoshan Zhang, Tongqing Zhou, Michael Gordon Joyce, Yongping Yang
  • Patent number: 10782339
    Abstract: Automatic test equipment with multiple components to generate highly accurate and stable analog test signals and method for operating the test system in semiconductor manufacturing process are disclosed. Output analog signals from existing test systems often fail the stability and accuracy requirement with less than 10 mV variations for testing certain electronic devices, due in part to environmental condition variations such as temperature fluctuations. Traditional compensation mechanisms for temperature variations involve time consuming and disruptive calibration procedures. Disclosed here is a system and method that provides near real-time monitoring and compensation for temperature-induced variations via a digital control mechanism that compensates for environmental variations in a time scale of less than 10 milliseconds and maintains the AC output analog signal with 10 milliVolt accuracy.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: September 22, 2020
    Assignee: Teradyne, Inc.
    Inventors: Zai-man Chen, Pei-Lai Zhang
  • Patent number: 10441111
    Abstract: An apparatus for grinding a mineral includes a head operable to be attached to a bottle. The head includes a radial slider for controlling the coarseness of the grind. The apparatus further includes an inner grinding element, an outer grinding element, a shaft, and a neck sleeve. The inner grinding element is in communication with the head. The outer grinding element is also in communication with the head, wherein the outer grinding element and the inner grinding element are operable to rotate relative to each other. The shaft extends through the inner grinding element and the outer grinding element. The shaft couples with the inner grinding element and comprises a blunt end. The shaft also extends through the neck sleeve, which acts as a spacer between the inner grinding element and the blunt end.
    Type: Grant
    Filed: January 13, 2015
    Date of Patent: October 15, 2019
    Assignee: B&G FOODS NORTH AMERICA, INC.
    Inventors: Allan E. Wade, Aaron F. Fitchko, Chun Man Chen, Alex Liu
  • Publication number: 20190218315
    Abstract: A compound of formula (I): R1O—(CH2CH2O)x—(CH2CH(R2)—O)y—SO3M, wherein R1, R2, x, y and M are defined herein. A composition comprising the compound of formula (I) and the use thereof.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 18, 2019
    Inventors: Mingxing HUANG, Peng XU, Zhihua ZHANG, Man CHEN
  • Publication number: 20190128954
    Abstract: Automatic test equipment with multiple components to generate highly accurate and stable analog test signals and method for operating the test system in semiconductor manufacturing process are disclosed. Output analog signals from existing test systems often fail the stability and accuracy requirement with less than 10 mV variations for testing certain electronic devices, due in part to environmental condition variations such as temperature fluctuations. Traditional compensation mechanisms for temperature variations involve time consuming and disruptive calibration procedures. Disclosed here is a system and method that provides near real-time monitoring and compensation for temperature-induced variations via a digital control mechanism that compensates for environmental variations in a time scale of less than 10 milliseconds and maintains the AC output analog signal with 10 milliVolt accuracy.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 2, 2019
    Inventors: Zai-man Chen, Pei-Lai Zhang
  • Publication number: 20190112340
    Abstract: Embodiments of a recombinant Respiratory Syncytial Virus (RSV) F ectodomain trimer stabilized in a prefusion conformation are provided. Also disclosed are nucleic acids encoding the RSV F ectodomain trimer and methods of producing the RSV F ectodomain trimer. Methods for inducing an immune response in a subject are also disclosed. In some embodiments, the method can be a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the recombinant RSV F ectodomain trimer to the subject.
    Type: Application
    Filed: March 29, 2017
    Publication date: April 18, 2019
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human
    Inventors: Peter Kwong, Barney Graham, John Mascola, Li Ou, Aliaksandr Druz, Man Chen, Wing-Pui Kong, Ivelin Stefanov Georgiev, Emily Rundlet, Michael Gordon Joyce, Yaroslav Tsybovsky, Paul Thomas, Marie Pancera, Mallika Sastry, Cinque Soto, Joseph Van Galen, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Ulrich Baxa
  • Patent number: 10141132
    Abstract: The present invention discloses a dual-actuator switch, comprising: a base, a first electrical connection member, a second electrical connection member, a first isolation sleeve cylinder, a second isolation sleeve cylinder, a first actuator, a second actuator, and a cover. By pressing one of the two actuators to drive one of the two isolation sleeve cylinders to rotate, the isolation sleeve cylinder is driven to prop one of the two electrical connection members by a protrusion member thereof, such that one of two switching operations is carried out. It is worth noting that, the electrical connection members are isolated from the actuators by the isolation sleeve cylinders during the whole electrical switching procedures. As a result, ambient moisture is absolutely blocked from getting into the base for infiltrating the electrical connection members during the up and/or down motion of the actuators.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: November 27, 2018
    Assignees: SOLTEAM ELECTRONICS (DONG GUAN) CO., LTD., SOLTEAM ELECTRONICS (SU ZHOU) CO., LTD., SOLTEAM ELECTRONICS CO., LTD.
    Inventors: Kuo-Jui Tseng, Chi-Meng Phang, Chien-Man Chen
  • Publication number: 20180319846
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Application
    Filed: July 2, 2018
    Publication date: November 8, 2018
    Applicant: The United States of America,as represented by the Secretary,Department of Helath and Human Services
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou
  • Patent number: 10017543
    Abstract: Disclosed are Respiratory Syncytial Virus (RSV) antigens including a recombinant RSV F protein stabilized in a prefusion conformation. Also disclosed are nucleic acids encoding the antigens and methods of producing the antigens. Methods for generating an immune response in a subject are also disclosed. In some embodiments, the method is a method for treating or preventing a RSV infection in a subject by administering a therapeutically effective amount of the antigen to the subject.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: July 10, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Peter D. Kwong, Barney S. Graham, Jason S. McLellan, Jeffrey Boyington, Lei Chen, Man Chen, Gwo-Yu Chuang, Ivelin Stefanov Georgiev, Jason Gorman, Michael Gordon Joyce, Masaru Kanekiyo, Gilad Ofek, Marie Pancera, Mallika Sastry, Cinque Soto, Sanjay Srivatsan, Guillaume Stewart-Jones, Yongping Yang, Baoshan Zhang, Tongqing Zhou